ID

36593

Description

Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient; ODM derived from: https://clinicaltrials.gov/show/NCT02069418

Link

https://clinicaltrials.gov/show/NCT02069418

Keywords

Versions (1)
  1. 5/24/19 5/24/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

May 24, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

English

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age over superior to 18
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
nsclc proved by a histological biopsy
Description

Non-Small Cell Lung Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0007131
egfr mutation status known with no activating egfr mutation
Description

EGFR gene mutation Status Known | EGFR Activating Mutation Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C3266992
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205309
UMLS CUI [2,1]
C2984891
UMLS CUI [2,2]
C0332197
indication of erlotinib therapy after at least one previous therapy
Description

Indication Erlotinib | Status post Prior Therapy Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C1135135
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C1514463
UMLS CUI [2,3]
C1265611
patients who have signed an informed consent to participate in this study
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
life expectancy exceeding 12 weeks
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
who activity score between 0 and 2.
Description

WHO Physical activity score

Data type

boolean

Alias
UMLS CUI [1,1]
C0043237
UMLS CUI [1,2]
C4482422
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindication for the initiation of erlotinib
Description

Medical contraindication Erlotinib

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1135135
refusal to sign the consent
Description

Informed Consent Refused

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
progressive inflammatory disease
Description

Inflammatory disorder Progressive

Data type

boolean

Alias
UMLS CUI [1,1]
C1290884
UMLS CUI [1,2]
C0205329
infection with the hiv virus
Description

HIV Infection

Data type

boolean

Alias
UMLS CUI [1]
C0019693
other malignant disease
Description

Malignant disease Other

Data type

boolean

Alias
UMLS CUI [1,1]
C0442867
UMLS CUI [1,2]
C0205394
life expectancy less than 12 weeks
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
major adults protected by french law
Description

Adult Protection Law France

Data type

boolean

Alias
UMLS CUI [1,1]
C0001675
UMLS CUI [1,2]
C0412786
UMLS CUI [1,3]
C0220866
UMLS CUI [1,4]
C0016674
Back to the top of the page

Similar models

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age over superior to 18
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma
Item
nsclc proved by a histological biopsy
boolean
C0007131 (UMLS CUI [1])
EGFR gene mutation Status Known | EGFR Activating Mutation Absent
Item
egfr mutation status known with no activating egfr mutation
boolean
C3266992 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205309 (UMLS CUI [1,3])
C2984891 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Indication Erlotinib | Status post Prior Therapy Quantity
Item
indication of erlotinib therapy after at least one previous therapy
boolean
C3146298 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Informed Consent
Item
patients who have signed an informed consent to participate in this study
boolean
C0021430 (UMLS CUI [1])
Life Expectancy
Item
life expectancy exceeding 12 weeks
boolean
C0023671 (UMLS CUI [1])
WHO Physical activity score
Item
who activity score between 0 and 2.
boolean
C0043237 (UMLS CUI [1,1])
C4482422 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Erlotinib
Item
contraindication for the initiation of erlotinib
boolean
C1301624 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
Informed Consent Refused
Item
refusal to sign the consent
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Inflammatory disorder Progressive
Item
progressive inflammatory disease
boolean
C1290884 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
HIV Infection
Item
infection with the hiv virus
boolean
C0019693 (UMLS CUI [1])
Malignant disease Other
Item
other malignant disease
boolean
C0442867 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy less than 12 weeks
boolean
C0023671 (UMLS CUI [1])
Adult Protection Law France
Item
major adults protected by french law
boolean
C0001675 (UMLS CUI [1,1])
C0412786 (UMLS CUI [1,2])
C0220866 (UMLS CUI [1,3])
C0016674 (UMLS CUI [1,4])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial